Markets:

Overview

News

Currencies

International

Treasuries

Revvity, Inc. Common Stock (NY:RVTY)

157.23 -6.25 (-3.82%)

Delayed Quote Updated: 10:02 AM EST, Nov 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revvity, Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Why Revvity (RVTY) Stock Is Falling Today

July 28, 2025

Shares of life sciences company Revvity (NYSE:RVTY) fell 7.6% in the afternoon session after the company lowered its full-year profit forecast, which overshadowed its second-quarter earnings and...

Via StockStory

Topics Lawsuit World Trade

Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’ ↗

July 28, 2025

Via Stocktwits

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

July 28, 2025

Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.

Via Chartmill

Oil, Energy Stocks Rise, Dollar Rallies On US-EU Trade Deal: What's Moving Markets Monday? ↗

July 28, 2025

Wall Street opened the week slightly higher, led by gains in energy stocks, while the U.S. dollar posted its strongest performance in over two months, as markets reacted to the U.S.-EU trade deal...

Via Benzinga

A Glimpse of Revvity's Earnings Potential ↗

July 25, 2025

Via Benzinga

Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today ↗

July 28, 2025

Tesla’s shares continued to rise on Monday, extending the surge from Friday after the company announced a $16.5 billion partnership with Samsung Electronics for semiconductor chips.

Via Stocktwits

Topics ETFs Government World Trade

Discover which S&P500 stocks are making waves on Monday. ↗

July 28, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

Via Chartmill

Revvity Slashes Outlook As China Policy Deals Diagnostics Blow ↗

July 28, 2025

Revvity beat Q2 earnings estimates but cut its 2025 profit outlook as China policy changes hit its immunodiagnostics business.

Via Benzinga

Gapping S&P500 stocks in Monday's session ↗

July 28, 2025

Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

Peering Into Revvity's Recent Short Interest ↗

June 30, 2025

Via Benzinga

Is the Market Bullish or Bearish on Revvity? ↗

May 21, 2025

Via Benzinga

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 28, 2025

Via Benzinga

Revvity Q2 Revenue Up 4 Percent ↗

July 28, 2025

Via The Motley Fool

Topics Economy

Revvity (NYSE:RVTY) Surprises With Q2 Sales

July 28, 2025

Life sciences company Revvity (NYSE:RVTY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.1% year on year to $720.3 million. The company expects the full year’s revenue to be...

Via StockStory

Revvity Announces Financial Results for the Second Quarter of 2025

July 28, 2025

From Revvity

Via Business Wire

Earnings Scheduled For July 28, 2025 ↗

July 28, 2025

Via Benzinga

What To Expect From Revvity’s (RVTY) Q2 Earnings

July 26, 2025

Life sciences company Revvity (NYSE:RVTY) will be reporting results this Monday morning. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

Revvity Board Declares Quarterly Dividend

July 24, 2025

From Revvity

Via Business Wire

Monday's session: gap up and gap down stock in the S&P500 index ↗

July 21, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know

July 18, 2025

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...

Via StockStory

Topics Lawsuit World Trade

Reflecting On Research Tools & Consumables Stocks’ Q1 Earnings: Revvity (NYSE:RVTY)

July 13, 2025

Let’s dig into the relative performance of Revvity (NYSE:RVTY) and its peers as we unravel the now-completed Q1 research tools & consumables earnings season.

Via StockStory

Topics Economy

Revvity to Hold Earnings Call on Monday, July 28, 2025

July 07, 2025

From Revvity

Via Business Wire

3 Low-Volatility Stocks in the Doghouse

July 03, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

What 9 Analyst Ratings Have To Say About Revvity ↗

June 26, 2025

Via Benzinga

1 Profitable Stock with Exciting Potential and 2 to Be Wary Of

June 18, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

3 Healthcare Stocks Skating on Thin Ice

June 04, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

June 02, 2025

From Revvity

Via Business Wire

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

May 19, 2025

From Revvity

Via Business Wire

3 Mid-Cap Stocks with Questionable Fundamentals

May 15, 2025

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.